Our people are vital to our success

StemMedical is a team of stem cell biologists, surgeons, quality professionals, process engineers and commercial experts who are passionate about getting Stem Cell Based treatment to patients. We have managed to overcome the three major barriers that has hindered getting stem cell treatments scaled. We still have lots of exciting work in front of us to reach patients broadly and work with partners across the world to do so.  




Klaus Langhoff-Roos

Former Head of Commercial Cell Therapy Division at Novo Nordisk
Responsible for Novo Nordisk’s entry into new therapy areas and for global launches of  blockbusters Ozempic® and Rybelsus®. Operating experience from US, Europe, RoW

Josef Christensen

Chief Business Development Officer

PhD in stem cell biology (Harvard) with extensive startup- and business experience

Formerly responsible for global commercialization of Novo Nordisk’s cell therapy asset

Previous partner in venture capital fund and 5+ years at McKinsey


Fred Koelle

Chief Scientific Officer, co-founder

Board certified Plastic Surgeon, MD, PhD

Head Plastic Surgeon, CeriX

Former Chief Plastic Surgeon, Aleris

PhD in stem cell technology for plastic surgery (Copenhagen University)

Michiel van Leeuwen

Chief Medical Officer

MD, PhD in plastic surgery at Vrije Universiteit in Amsterdam

Former VP of Global Medical Affairs at Novo Nordisk

Responsible for Novo Nordisk’s global launches of  blockbusters Ozempic® and Rybelsus®. 


Peter Selvig

Chief Operating/Financial Officer, co-founder

M.Sc. in Innovation & Business Development (CBS/UW, Madison) with extensive international business and operational experience.

Formerly responsible for special projects, business strategy, and marketing at Shell Nordics. 

Sales, trading and operational experience from Shell Trading.

Marc Fauerby Lange

Chief Commercial Officer
Specialised in startups and commercial expansion across various sectors.
Co-founded Cura Nordic OTC, leading it to acquisition by a Swedish firm in 3 years.
Founded Amp Capital with 10 years of strategic expertise and investment.
Former Head of Strategy at MEC Media Agency.

Anne L. F. Nielsen

Head of Quality & Regulatory, Co-founder

Board certified clinical 
immunologist, MD

Head of Cell Therapy, 
Copenhagen University Hospital

Former Assistant Professor in Immunology at Copenhagen University

Elhem Sbaa

Head of Regulatory Affairs

PhD in Stem Cell Biology,
>15 years experience in regulatory affairs

Former project manager at Tigenix®, and former head of Regulatory Affairs department at Keyrus Biopharma®


Lea Munthe-Fog

Head of Cell Research

PhD in Molecular Biology

Former  Head of GMP production at Rigshospitalet

+50 publications in peer reviewed journals, including NEJM
H-index 28 (i10-index 49)


Rest of Organisation

Jesper Due Jensen

PhD, MSc
Senior Clinical Project Manager

Frederik P. W. Mamsen

Research & Medical Affairs Specialist

Signe Baunehøj

Senior Excellence Manager

Sandra Adelheid Beyer

Clinical Specialist & Plastic Surgical Nurse

Jesper Svalgaard

PhD, MSc
Senior RD Scientist

Christian Bülow

Senior RD Scientist

Julie Nygaard

Lab Manager

Signe Ilsøe

Biomedical Laboratory Scientist

Tue Malthesen

Senior RD Scientist

Isja Palsgaard

Senior quality assurance specialist


Board of Directors

Stig Løkke Pedersen

Former Lundbeck EVP of Commercial Operations, Prof BOD member
To learn more, follow Stig on

Christian Riisberg

Vice Chairman

Senior Advisor 
Vendis Capital

Fred Koelle

Board member

CSO, MD, PhD, Co-Founder StemMedical

Christina M. Wengel

Board member

MD, Former ALK Abello SVP of Marketing

Nis Alstrup

Board member

MD, Former CEO of Aleris Hamlet, Surgeon, Danske Privathospitaler

Erik Aznauryan

Board member

PhD, Cell Engineering  Research Fellow
G. Church lab, Harvard

Anders Chr. Kølle

Board member

Partner at Kap Omega Research


Clinical Advisors


Aris Sterodimas, MD, PhD

Head of Plastic & Reconstructive Surgery, Metropolitan Hosp. Athens (GR)

Chia Chi Kao, MD, BC

Ass. Professor, Kao Plastic Surgery California (US)

Brad Calobrace, MD, FACS

Chairman of BTS, CaloAesthetics Plastic Surgery Center (US)
Adam Judd Katz

Prof. Adam J Katz, MD, PhD

Plastic Surgery at Wake Forrest School of Med., Founder GID Group, IFATS (US)

Life Science

Strategic Advisors

Thomas Ebeling

Thomas Ebeling

Former CEO Novartis Pharma, Chairman Galderma, Board Member Qiagen

Andreas Rummelt

Andreas Rummelt

Former CEO Sandoz, Board Member Astra-Zeneca, Board Member Xellia Pharma